Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00371215 · ClinicalTrials.gov registry record · Phase 2
Study of Recombinant Human Thrombin for Bleeding During Autologous Skin Grafting
A Phase 2 study, sponsored by ZymoGenetics.
- Completed
- Registry status
- Phase 2
- Development phase
- 72
- Enrollment target
NCT00371215 is a Phase 2 study that has completed, run by ZymoGenetics. The registered enrollment target is 72 participants.
The verdict
NCT00371215, a Phase 2 study, has completed, sponsored by ZymoGenetics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 72 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether rThrombin is safe when used for controlling bleeding during skin graft surgery.
Interventions
- BIOLOGICAL rThrombin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2006-08 |
| Est. Completion | 2007-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00371215
The ClinicalTrials.gov registry entry for NCT00371215 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ZymoGenetics, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which rThrombin is the first listed.
NCT00371215 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00371215 about?
NCT00371215 is a clinical study titled "Study of Recombinant Human Thrombin for Bleeding During Autologous Skin Grafting". The purpose of this study is to evaluate whether rThrombin is safe when used for controlling bleeding during skin graft surgery.
What is the current status of trial NCT00371215?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 72 participants. The study started on 2006-08. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00371215?
The interventions under investigation include: rThrombin (BIOLOGICAL).
Who is sponsoring clinical trial NCT00371215?
This trial is sponsored by ZymoGenetics, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.